Helping people with HIV quit smoking and improve their treatment outcomes
Patient-Oriented Substance Use/Smoking Cessation Research in HIV Treatment and Prevention
This study is all about helping new researchers create better ways for people living with HIV to quit smoking, while also looking at how smoking affects their treatment, so that everyone can get the best care possible.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11085607 on NIH RePORTER |
What this research studies
This research focuses on mentoring junior researchers to develop effective smoking cessation programs specifically for individuals living with HIV. It aims to understand how substance use impacts HIV treatment and outcomes, and to create integrated treatment approaches that enhance adherence to antiretroviral therapy. By emphasizing implementation science, the project seeks to ensure that new smoking cessation strategies are effectively applied in real-world settings, ultimately benefiting patients. The mentorship will also involve training on the development of tailored interventions for sub-populations of smokers with HIV.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who smoke and are seeking help to quit smoking.
Not a fit: Patients who do not smoke or are not living with HIV may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved smoking cessation rates and better health outcomes for individuals living with HIV.
How similar studies have performed: Previous research has shown promising results in integrating substance use treatment with HIV care, indicating that this approach could be effective.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: O'cleirigh, Conall Michael — Massachusetts General Hospital
- Study coordinator: O'cleirigh, Conall Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.